Martee L. Hensley, M.D., M.Sc. is a medical oncologist specializing in the treatment of gynecologic cancers. Her clinical research and academic oncology practice are dedicated to improving the lives of women with gynecologic sarcomas. Dr. Hensley has served as principal investigator for national and international studies in gynecologic sarcomas. She serves as co-Chair of the National Cancer Institute’s Uterine Task Force.  She is the U.S. Chair for the International Rare Cancer Initiative-gynecologic sarcoma group.  She is Editor-in-Chief for the American Society of Clinical Oncology-Self Evaluation Program (ASCO-SEP).  She received her MD degree in 1989 from Duke University School of Medicine, completed her internship and residency in internal medicine, and her fellowship in hematology and medical oncology, at The New York Presbyterian Hospital-Cornell.  She received her M.Sc. from Harvard School of Public Health in 1998. She joined the faculty of Memorial Sloan Kettering Cancer Center in 1998, where she is currently Attending Physician, Gynecologic Medical Oncology service, and Professor of Medicine, Weill Cornell Medical College.  Since January 2016, she has served as Chair of the Hospital Quality Assessment Committee.

Dr. Milosevic is a radiation oncologist in the Radiation Medicine Program, Princess Margaret Cancer Centre and University Health Network, Toronto, Canada. He is a Professor  and  the  Vice-­‐Chair  of  Research  in  the  Department  of  Radiation  Oncology  at the  University  of  Toronto,  a  past-­‐President  of  the  Canadian  Association  of  Radiation Oncology (CARO) and the Chair of the Canadian Partnership for Quality in Radiotherapy (CPQR). Dr. Milosevic’s clinical practice is focused on the management of women with gynecological cancers. His research revolves around the influence of hypoxia and other biological determinants of gynecological cancer behavior and radiation treatment response, molecular therapeutics to overcome radiation treatment resistance, and the application of adaptive, MR-­‐guided external beam radiotherapy and brachytherapy.

Dr. Jessica McAlpine is an Associate Professor in the Department of Gynecology, Division of Gynecologic Oncology at the University of British Columbia and BC Cancer Agency, Vancouver, Canada. She did her medical training in the US; medical school at Johns Hopkins, residency at Stanford in Obstetrics and Gynecology, and Fellowship at Yale in Gynecologic Oncology.  She currently splits her time equally between surgical/clinical work and translational research.  She is part of the OVCARE research team (British Columbia’s Ovarian Cancer Research group), Director of the OVCARE Tissue Bank and recipient of a CIHR New Investigator Award (2013-2018) and BC Cancer Foundations Clinician Scientist Award (2016-2021). Her research focuses on molecular/genomic characterization of ovarian, endometrial and vulvar cancers as well as ovarian cancer prevention.